psa testing guidelines - Viral Trends
The criteria for consideration of genetic testing for prostate cancer varies depending on the current guidelines and expert opinion consensus, as summarized in Table 2. [1 - 5] Hereditary prostate cancer genetic testing criteria are based on an individual's family history, personal/disease characteristics, and tumor sequencing results. Prostate-specific antigen, or PSA, is a protein produced by normal, as well as malignant, cells of the prostate gland.
Understanding the Context
Both prostate cancer and several benign conditions (particularly benign prostatic hyperplasia, or BPH, and prostatitis) can cause PSA levels in the blood to rise. The PSA test measures the level of PSA in the blood. Prostate cancer screening with the prostate-specific antigen (PSA) test or digital rectal exams has not been shown to reduce prostate cancer deaths. Get detailed information about prostate cancer screening, including potential benefits and harms, in this summary for clinicians.
Image Gallery
Key Insights
Prostate-specific antigen, or PSA, is a protein produced by normal, as well as malignant, cells of the prostate gland. The PSA test measures the level of PSA in a man’s blood. For this test, a blood sample is sent to a laboratory for analysis. In 2012 the U.S. Preventive Services Task Force (USPSTF) recommended against prostate cancer screening.
Related Articles You Might Like:
when should you take the plan b pill sports and games in the middle ages is easy bruising a sign of cancerFinal Thoughts
Prostate Cancer Screening Recommendations According to the U.S. Preventive Services Task Force (USPSTF), for men aged 55 to 69 years, the decision should be individually made to undergo periodic prostate-specific antigen (PSA)-based screening for prostate cancer. Learn about prostate changes and symptoms that are not cancer, plus risk factors and treatment for prostatitis, enlarged prostate (BPH), prostate cancer. Talk with your doctor about prostate cancer screening tests (DRE, PSA). A rapid increase in prostate-specific antigen (PSA) levels is not grounds for automatically recommending a prostate biopsy, according to a study published online , in the Journal of the National Cancer Institute.